187 related articles for article (PubMed ID: 210263)
1. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
Takamori M; Sakato S; Okumura S
J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
Engel AG
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
Kim YI
Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
[TBL] [Abstract][Full Text] [Related]
5. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
Chiu HC; Chen ML; Tsai MC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):217-23. PubMed ID: 2827968
[TBL] [Abstract][Full Text] [Related]
6. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
[TBL] [Abstract][Full Text] [Related]
7. The immunopathology of myasthenia gravis.
Engel AG
Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
[TBL] [Abstract][Full Text] [Related]
9. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.
Rash JE; Albuquerque EX; Hudson CS; Mayer RF; Satterfield JR
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4584-8. PubMed ID: 1070009
[TBL] [Abstract][Full Text] [Related]
10. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
Mossman S; Vincent A; Newsom-Davis J
J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
Pagala MK; Tada S; Namba T; Grob D
Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis: passive transfer from man to mouse.
Toyka KV; Brachman DB; Pestronk A; Kao I
Science; 1975 Oct; 190(4212):397-9. PubMed ID: 1179220
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of myasthenia gravis.
Heilbronn E; StÄlberg E
J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
[No Abstract] [Full Text] [Related]
15. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
[No Abstract] [Full Text] [Related]
16. How myasthenia gravis alters the safety factor for neuromuscular transmission.
Ruff RL; Lennon VA
J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
[TBL] [Abstract][Full Text] [Related]
17. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
18. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Burres SA; Crayton JW; Gomez CM; Richman DP
Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
[TBL] [Abstract][Full Text] [Related]
20. Immunopathology of myasthenia gravis.
Drachman DB
Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
[No Abstract] [Full Text] [Related]
[Next] [New Search]